A Prospective, Open Clinical Study to Examine the Efficacy and Safety of Neoadjuvant Tislelizumab Combined With Cisplatin-based Chemotherapy in Patients With Locally Advanced Upper Urinary Tract Urothelial Carcinoma
Latest Information Update: 06 Dec 2022
At a glance
- Drugs Cisplatin (Primary) ; Tislelizumab (Primary) ; Gemcitabine
- Indications Carcinoma; Urogenital cancer
- Focus Therapeutic Use
- 23 Dec 2020 New trial record